new_0222_0360|TARS|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0360|TARS|1|Tarsus Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Inventories (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Book Value (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Tarsus Pharmaceuticals Inc EV to Revenues|Tarsus Pharmaceuticals Inc EV to Earnings|Tarsus Pharmaceuticals Inc EV to Free Cash Flow|Tarsus Pharmaceuticals Inc EV to Assets (Quarterly)|Tarsus Pharmaceuticals Inc PS Ratio|Tarsus Pharmaceuticals Inc PE Ratio|Tarsus Pharmaceuticals Inc Price to Book Value|Tarsus Pharmaceuticals Inc PEG Ratio|Tarsus Pharmaceuticals Inc Debt to Equity Ratio|Tarsus Pharmaceuticals Inc Dividend Yield|Tarsus Pharmaceuticals Inc Shareholder Yield (TTM)|Tarsus Pharmaceuticals Inc Percent of Shares Outstanding Short|Tarsus Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Return on Invested Capital|Tarsus Pharmaceuticals Inc Quality Ratio Score|Tarsus Pharmaceuticals Inc Momentum Score|Tarsus Pharmaceuticals Inc Beta (1Y)|Tarsus Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Tarsus Pharmaceuticals Inc Institutional Investor Ownership Percentage|Tarsus Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Tarsus Pharmaceuticals Inc Total Employees (Annual)|Tarsus Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Shares Outstanding|Tarsus Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Tarsus Pharmaceuticals Inc Payout Ratio|Tarsus Pharmaceuticals Inc Quick Ratio (Quarterly)|Tarsus Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Effective Tax Rate (TTM)|Tarsus Pharmaceuticals Inc Return on Equity|Tarsus Pharmaceuticals Inc Net Income (TTM) (USD)|Tarsus Pharmaceuticals Inc Revenue (TTM) (USD)|Tarsus Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Revenue (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Tarsus Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Net Income (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Tarsus Pharmaceuticals Inc Price (USD)|Tarsus Pharmaceuticals Inc Total Return Price (USD)|Tarsus Pharmaceuticals Inc Enterprise Value (USD)|Tarsus Pharmaceuticals Inc 30-Day Average Daily Volume|Tarsus Pharmaceuticals Inc 1 Year Price Returns (Daily)||
new_0222_0360|TARS|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0360|TARS|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0360|TARS|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|0|0|1.44839857651|91.5|0|0|1.44839857651|0|91.5|1.45045045045|0|15.2666666667|106.5|106.5|106.5|0|0|31|30.6666666667|0|30.5|91.375|92|91.375|35.5454545455|91.2|106.5|0|91.5|91.375|0|91.4|0|91.4|0|0|91.5|91.3333333333|91.375|91.375|91.375|91.375|1.45045045045|1.45045045045|1.45045045045|1.45065789474|1.43209876543||
new_0222_0360|TARS|6|6|6|0|6|0|6|6|6|0|6|6|0|0|0|281|2|0|0|281|0|2|333|0|30|6|6|6|0|0|2|3|0|14|8|1|8|11|5|6|0|2|8|0|5|0|5|0|0|2|6|8|8|8|8|333|333|333|304|81||
new_0222_0360|TARS|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0360|TARS|201909||||||||||||||||||||||||||||||||||10.9008||-0.0625||||||-0.06|||||||||0.234|-0.681|-0.681|-0.021|||||||
new_0222_0360|TARS|201912|58.03|57.952||0.28||64.321|0.819|63.502||-6.005|-6.034||||||||||||||0.036|0.456|0.002|||||||10.9008||-0.1295|||18.759|||-0.1016|||||||||0.387|-1.412|-1.412|-0.024|||||||
new_0222_0360|TARS|202003||||||||||||||||||||||||||||||||||10.9008||-0.1795||-0.027||||-0.1795||||||||0|0.606|-1.957|-1.957|0.161|||||||
new_0222_0360|TARS|202006|54.706|53.135||1.395||3.872|3.075|0.797||52.367|-11.241||||||||||||||0.002|1.42|0.001|||||||10.9008||-0.2981||-0.001|18.759|||-0.2981||0||-7.3||||0|1.526|-3.25|-3.25|0.013|||||||
new_0222_0360|TARS|202009|89.072|86.329||1.363||110.014|6.144|103.87||-17.829|-21.379|||||||||||0||0.6997|0.001|4.706|0.002||||||57.7574|18.759|18|-0.5404|19.259|0.028|18.759|||-0.5404||-0.006||-16.757||||0|2.15|-10.137|-10.138|0.004|20.44|20.44|307.325|73021.5667||24.17|
new_0222_0360|TARS|202012|170.655|168.129||1.236||5.992|5.387|0.605||165.98|-32.845||||-31.1118||||5.0606|||0||1.9612|0.02|2.237|0.004|||||||20.3232|20|-0.5642|20.3232|-0.028|20.3232|||-0.5642||-0.0037||-26.812|||||3.89|-11.467|-11.467|0.01|41.33|41.33|671.8289|145568.4||37.7|36.25
new_0222_0360|TARS|202103|191.451|156.179||1.173||10.722|10.118|0.604||183.232|-22.469||||-16.0263|2.6054|||3.6102||0|0||1.9795|32.446|5.31|0.004|||||||21.8246||0.47|20.5245||20.5245||18.6425|0.47||-2.2167||-14.479|||33.432|32.135|5.16|10.689|10.376|0.009|32.23|32.23|505.3256|36852.9||30.72|33.32
new_0222_0360|TARS|202106|200.904|176.735||1.021||10.979|10.455|0.524||192.471|-16.124||||-51.7645|2.0619|||3.0978||0|0||1.5433|20.157|3.645|0.004|||||||21.9666||0.29|20.574|0|20.574||18.8323|0.3297||-7.5534||-4.884|||22.017|21.28|6.794|6.374|6.345|0.007|28.98|28.98|419.4995|94439.7333||22.57|26.5
new_0222_0360|TARS|202109|187.088|183.801||1.709||11.27|10.365|0.905||179.142|-31.821||||46.7753|1.3742|||2.4866||0|0||1.5917|0.139|2.01|0.004|||6|2.8069|||20.6413||-0.76|20.6711||20.6711||17.7463|-0.7436||-0.0096||-10.443|||1.24|1.175|6.671|-16.038|-15.697|0.008|21.55|21.55|261.6612|23931.9667|44.8096|27.76|26.6
new_0222_0360|TARS|202112|||||||||||||||50.3095||||2.597|||0||1.5725||||||5|2.0169||80.1887||||||||||||||||||||||22.5|22.5|281.4315|22253.0667|-45.5601|20.07|14.49